시장보고서
상품코드
1532813

바이오필름 치료 시장 : 제품 유형별, 상처 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Biofilms Treatment Market, By Product Type, By Wound Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

바이오필름 치료 시장 규모는 2023년 21억 932만 달러로 2024-2032년 연평균 7.98% 성장할 것으로 예상됩니다.

바이오필름 치료 시장 - 시장 역학

만성 감염과 수술의 증가로 인해 효과적인 바이오필름 치료 솔루션에 대한 수요가 증가하고 있습니다.

전 세계적으로 만성 감염의 증가와 외과 수술의 증가는 효과적인 바이오필름 치료 솔루션의 시급한 필요성을 강조하고 있습니다. 세계보건기구(WHO)에 따르면, 바이오필름으로 인해 악화되는 만성 상처는 매년 전 세계적으로 수백만 명이 앓고 있으며, 이로 인해 입원 기간이 길어지고 의료비 지출이 급증하고 있습니다. 만성 상처의 전 세계 유병률은 인구 1,000명당 1.67명으로 보고되고 있으며, 그 중 만성 하지 궤양은 1,000명당 1.51명으로 가장 높은 비율을 차지하고 있습니다.

바이오필름은 항생제에 저항하고 면역 반응을 회피함으로써 치료를 크게 복잡하게 만들고 회복 기간을 연장하며 합병증 위험을 증가시킵니다. 따라서 의료 제공자와 연구자들은 바이오필름 구조를 파괴하고 환자 결과를 개선하기 위한 치료법과 기술을 혁신해야 하는 과제를 안고 있습니다. 의료 시스템이 이러한 심각한 도전에 대응하고 환자 치료 및 감염 관리의 진화하는 요구에 부응하기 위해서는 바이오필름 연구 및 개발에 대한 투자가 매우 중요합니다.

바이오필름 치료 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 7.98%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 드레싱(거즈, 드레싱)이 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

상처 유형별로는 2023년 욕창이 주요 유형으로 부상했습니다.

지역별로는 북미가 2023년 매출 1위

바이오필름 치료 시장 - 세분화 분석:

바이오필름 치료 세계 시장은 제품 유형, 상처 유형, 최종사용자 및 지역별로 분류됩니다.

시장은 제품 유형에 따라 이식 및 매트릭스, 겔, 연고 및 스프레이, 데브리드만 장비, 거즈 및 드레싱 재료,(물티슈, 패드, 세척액) 등 6가지로 나뉩니다. 거즈 및 드레싱 재료는 일반적으로 상처 치료 및 생물막 치료 시장에서 가장 많이 판매됩니다. 드레싱 재료는 상처를 덮고, 보호 장벽을 제공하고, 삼출물을 흡수하고, 치유를 촉진하는 데 필수적입니다. 드레싱 재료는 거즈, 비접착성 드레싱 재료, 하이드로콜로이드, 하이드로겔, 폼 드레싱 등 다양한 형태로 제공되며 상처 유형과 치유 단계에 따라 다릅니다.

시장은 상처 유형에 따라 욕창, 당뇨병성 족부궤양, 외과적 및 외상성 상처, 화상 및 기타 개방성 상처, 정맥성 하지 궤양 등 5가지 범주로 나뉩니다. 욕창은 욕창이라고도 불리며 가장 흔한 상처 중 하나입니다. 욕창은 움직일 수 없거나 누워있는 사람의 피부에 장시간 압력이 가해지면 발생합니다. 이러한 궤양은 보통 엉덩이, 발뒤꿈치, 천골과 같은 뼈의 융기 부위에 발생합니다. 욕창은 의료 환경, 특히 노인, 거동이 불편한 사람, 만성 질환을 앓고 있는 사람에게서 많이 발생합니다. 욕창의 중증도는 경미한 발적부터 하부 조직에 영향을 미치는 깊은 상처까지 다양합니다.

바이오필름 치료 시장 - 지리적 인사이트

북미 바이오필름 치료 시장은 높은 수준의 의료 인프라와 막대한 의료비 지출에 힘입어 바이오필름으로 인한 만성 감염 및 상처 관리에 초점을 맞춘 광범위한 연구 개발이 진행되고 있습니다. 주요 제약 및 의료기기 기업들은 혁신적인 신생 기업들과 함께 이 부문에서 경쟁과 혁신을 주도하고 있습니다. 이 분야에서 가장 많이 팔리는 제품으로는 3M(TM) Cavilon(TM) Advanced Skin Protectant, Smith &Nephew Allevyn Ag, Coloplast Biatain(R)Ag, Molnlycke Mepilex Ag, Zimmer Biomet Orthopedic Wound Gel 등이 있습니다. 미국과 캐나다의 규제 프레임워크는 시장 진입과 제품 승인에 유리한 환경을 조성하여 바이오필름 치료 기술의 발전을 촉진하고 있습니다. 학계, 산업계, 정부 기관의 협력은 성장과 혁신을 더욱 촉진하고 있으며, 북미는 바이오필름 치료 솔루션의 미래를 형성하는 주요 지역으로 자리매김하고 있습니다.

바이오필름 치료 시장 - 경쟁 상황:

바이오필름 치료 시장의 경쟁 구도는 주요 기업과 혁신 기술에 의해 주도되고 있으며, Smith Nephew, Coloplast Group, Molnlycke Healthcare AB와 같은 주요 기업들이 다양한 의료 응용 분야에서 바이오필름을 대상으로 하는 의료기기 및 솔루션 포트폴리오를 통해 우위를 점하고 있습니다. 다양한 의료 응용 분야에서 바이오필름을 대상으로 하는 광범위한 포트폴리오로 우위를 점하고 있습니다. 이들 기업은 바이오필름과 관련된 문제를 관리하기 위한 제품 제공과 효능을 향상시키기 위해 연구개발에 많은 투자를 하고 있습니다. 케인 바이오텍(Kane Biotech)과 같은 신생 기업들은 바이오필름의 회복력과 건강 상태를 악화시키는 바이오필름의 의미에 초점을 맞춘 코액티브(coactiv(TM))와 같은 새로운 기술을 도입하고 있습니다. 이러한 발전은 바이오필름을 효과적으로 파괴할 수 있는 혁신적인 솔루션에 대한 중요성이 커지고 있음을 보여줍니다.

업계에서 진행 중인 협력과 전략적 파트너십은 바이오필름 치료 전략의 진전을 촉진하는 동시에 경쟁을 더욱 치열하게 하고 복합적인 전문 지식과 자원을 활용하기 위한 것입니다. 이러한 역동적인 상황은 의료 환경 전반에 걸쳐 바이오필름과 관련된 복잡성에 대응하기 위한 공동의 노력을 반영하고 있습니다.

목차

제1장 바이오필름 치료 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 바이오필름 치료의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 바이오필름 치료 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 바이오필름 치료 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 바이오필름 치료 시장 상황

  • 바이오필름 치료 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 바이오필름 치료 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 이식편과 매트릭스
    • 젤, 연고, 스프레이
    • 괴사조직제거 기기
    • 거즈와 붕대
    • 물티슈, 패드, 세정액

제8장 바이오필름 치료 시장 - 창상 유형별

  • 개요
    • 창상 유형별 부문 점유율 분석
    • 욕창
    • 당뇨병성 족부궤양
    • 외과수술과 외상
    • 화상이나 기타 개방창
    • 정맥성 다리궤양

제9장 바이오필름 치료 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원, ASC, 창상관리 센터
    • 재택의료
    • 기타

제10장 바이오필름 치료 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 바이오필름 치료 업계

  • 경쟁 대시보드
  • 기업 개요
    • Smith+Nephew
    • MiMedx
    • ConvaTec Group plc
    • Coloplast Group
    • Molnlycke Healthcare AB
    • Organogenesis Inc.
    • Integra LifeSciences
    • B. Braun Melsungen AG
    • PAUL HARTMANN AG
    • Medline Industries Inc.
    • Acelity
    • Zimmer Biomet
    • Novozymes A/S
    • 3M Company
    • Pfizer Inc.

제12장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Biofilms Treatment Market size was valued at USD 2,109.32 Million in 2023, expanding at a CAGR of 7.98% from 2024 to 2032.

Biofilms are structured communities of bacteria that adhere to surfaces and are enclosed within a protective matrix of extracellular polymeric substances (EPS). They are resilient and can form on various surfaces within the body, such as wounds, medical implants, and mucosal membranes. Biofilms pose a significant challenge in healthcare settings as they enhance bacterial resistance to antibiotics and immune responses, leading to persistent infections. Effective biofilm treatment strategies aim to disrupt their structure and remove them from affected areas, often involving specialized antimicrobial agents and advanced wound care techniques.

Biofilms Treatment Market- Market Dynamics

The rising incidence of chronic infections and surgical procedures fuels the demand for effective biofilm treatment solutions

The increasing occurrence of chronic infections and rising surgical procedures worldwide highlight the urgent necessity for effective biofilm treatment solutions. According to the World Health Organization (WHO), chronic wounds, often aggravated by biofilms, affect millions globally each year, leading to extended hospital stays and escalated healthcare expenses. The prevalence of chronic wounds globally is reported at 1.67 per 1,000 people, with chronic leg ulcers accounting for 1.51 per 1,000.

Biofilms significantly complicate treatment by resisting antibiotics and evading immune responses, thereby prolonging recovery periods and heightening the risk of complications. This challenges healthcare providers and researchers to innovate therapies and technologies aimed at disrupting biofilm structures and enhancing patient outcomes. Investment in biofilm research and development is crucial as healthcare systems address these escalating challenges and adapt to meet evolving needs in patient care and infection management.

Biofilms Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.98% over the forecast period (2024-2032)

Based on Product type segmentation, Dressings (gauzes and dressings) was predicted to show maximum market share in the year 2023

Based on Wound Type segmentation, Pressure ulcers were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Biofilms Treatment Market- Segmentation Analysis:

The Global Biofilms Treatment Market is segmented on the basis of Product Type, Wound Type, End User, and Region.

The market is divided into six categories based on Product type: Grafts & Matrices, Gels, Ointments & Sprays, Debridement Equipment, Gauzes & Dressings, and (Wipes, Pads, & Lavage Solutions). Gauzes and dressings are typically sold the most in the context of wound care and biofilms treatment markets. Dressings are essential for covering wounds, providing a protective barrier, absorbing exudate, and promoting healing. They come in various forms such as gauzes, non-adherent dressings, hydrocolloids, hydrogels, and foam dressings, catering to different wound types and stages of healing.

The market is divided into five categories based on Wound Type: Pressure Ulcers, Diabetic Foot Ulcers, Surgical & Traumatic Wounds, Burns & Other Open Wounds, and Venous Leg Ulcers. Pressure ulcers, also known as bedsores or pressure sores, are among the most common types of wounds. They occur due to prolonged pressure on the skin, often in individuals who are immobile or bedridden. These ulcers typically develop over bony prominences such as the hips, heels, and sacrum. They are prevalent in healthcare settings, especially among elderly patients, individuals with limited mobility, and those with chronic illnesses. Pressure ulcers can vary in severity from mild redness to deep wounds that affect underlying tissues.

Biofilms Treatment Market- Geographical Insights

North America's biofilms treatment market is supported by advanced healthcare infrastructure and substantial healthcare spending, facilitating extensive research and development efforts focused on managing chronic infections and wounds caused by biofilms. Major pharmaceutical and medical device companies, alongside innovative startups, drive competition and innovation in this sector. Some of the top-selling products in the region include 3M(TM) Cavilon(TM) Advanced Skin Protectant, Smith & Nephew Allevyn Ag, Coloplast Biatain(R) Ag, Molnlycke Mepilex Ag, and Zimmer Biomet Orthopedic Wound Gel. Regulatory frameworks in the United States and Canada create a favorable environment for market entry and product approval, encouraging advancements in biofilms treatment technologies. Collaborations among academia, industry, and government agencies further stimulate growth and innovation, positioning North America as a leading region in shaping the future of biofilms treatment solutions.

Biofilms Treatment Market- Competitive Landscape:

The biofilms treatment market features a competitive landscape driven by key players and innovative technologies. Major companies such as Smith+Nephew, Coloplast Group, and Molnlycke Healthcare AB dominate with extensive portfolios of medical devices and solutions targeting biofilms across various medical applications. These players invest significantly in research and development to enhance their product offerings and effectiveness in managing biofilm-related challenges. Established players, and emerging companies like Kane Biotech are introducing novel technologies like coactiv+(TM), which specifically target biofilms' resilience and their implications in exacerbating health conditions. These advancements underscore a growing emphasis on innovative solutions that disrupt biofilms effectively.

Ongoing collaborations and strategic partnerships within the industry aim to leverage combined expertise and resources, further intensifying competition while fostering advancements in biofilms treatment strategies. This dynamic landscape reflects a concerted effort towards addressing the complexities associated with biofilms across healthcare settings.

Recent Developments:

In July 2024, Kane Biotech Inc. entered into a global licensing agreement with Bioceutical Innovations Inc. for its coactiv+(TM) range of scalp care products. This product line from Kane targets minor health issues exacerbated by biofilms, featuring their patented coactiv+(TM) technology.

In Jan 2024, 3M's Medical Solutions Division received a $34.2 million award from the U.S. The initiative focuses on designing treatment strategies tailored for complex environments, including mass casualty scenarios and situations with delayed evacuation capabilities.

In Oct 2023, Penrhos Bio, a cleantech bioscience company based in Scotland, has secured £3 million in Series A funding.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOFILMS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Smith+Nephew

MiMedx

ConvaTec Group plc

Coloplast Group

Molnlycke Healthcare AB

Organogenesis Inc.

Integra LifeSciences

B. Braun Melsungen AG

PAUL HARTMANN AG

Medline Industries Inc.

Acelity

Zimmer Biomet

Novozymes A/S

3M Company

Pfizer Inc.

GLOBAL BIOFILMS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Grafts and Matrices
  • Gels, Ointments, and Sprays
  • Debridement Equipment
  • Gauzes and Dressings
  • Wipes, Pads, and Lavage Solutions

GLOBAL BIOFILMS TREATMENT MARKET, BY WOUND TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Surgical and Traumatic Wounds
  • Burns and Other Open Wounds
  • Venous Leg Ulcers

GLOBAL BIOFILMS TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals, ASCs, and Wound Care Centers
  • Home Care Settings
  • Other End Users

GLOBAL BIOFILMS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biofilms Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biofilms Treatment Market Snippet by Product Type
    • 2.1.2. Biofilms Treatment Market Snippet by Wound Type
    • 2.1.3. Biofilms Treatment Market Snippet by End User
    • 2.1.4. Biofilms Treatment Market Snippet by Country
    • 2.1.5. Biofilms Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Biofilms Treatment Key Market Trends

  • 3.1. Biofilms Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biofilms Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biofilms Treatment Market Opportunities
  • 3.4. Biofilms Treatment Market Future Trends

4. Biofilms Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biofilms Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biofilms Treatment Market Landscape

  • 6.1. Biofilms Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biofilms Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Grafts and Matrices
    • 7.1.3. Gels, Ointments, and Sprays
    • 7.1.4. Debridement Equipment
    • 7.1.5. Gauzes and Dressings
    • 7.1.6. Wipes, Pads, and Lavage Solutions

8. Biofilms Treatment Market - By Wound Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Wound Type, 2023 & 2032 (%)
    • 8.1.2. Pressure Ulcers
    • 8.1.3. Diabetic Foot Ulcers
    • 8.1.4. Surgical and Traumatic Wounds
    • 8.1.5. Burns and Other Open Wounds
    • 8.1.6. Venous Leg Ulcers

9. Biofilms Treatment Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals, ASCs, and Wound Care Centers
    • 9.1.3. Home Care Settings
    • 9.1.4. Other End Users

10. Biofilms Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biofilms Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biofilms Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biofilms Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Biofilms Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Biofilms Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biofilms Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Smith+Nephew
    • 11.2.2. MiMedx
    • 11.2.3. ConvaTec Group plc
    • 11.2.4. Coloplast Group
    • 11.2.5. Molnlycke Healthcare AB
    • 11.2.6. Organogenesis Inc.
    • 11.2.7. Integra LifeSciences
    • 11.2.8. B. Braun Melsungen AG
    • 11.2.9. PAUL HARTMANN AG
    • 11.2.10. Medline Industries Inc.
    • 11.2.11. Acelity
    • 11.2.12. Zimmer Biomet
    • 11.2.13. Novozymes A/S
    • 11.2.14. 3M Company
    • 11.2.15. Pfizer Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제